These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3528320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.
    Johnson DE, Calia FM, Snyder MJ, Warren JW, Schimpff SC.
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():89-96. PubMed ID: 6583199
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer.
    Wade JC, Standiford HC, Drusano GL, Johnson DE, Moody MR, Bustamante CI, Joshi JH, deJongh C, Schimpff SC.
    Am J Med; 1985 Jun 07; 78(6A):62-72. PubMed ID: 3859217
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD, Pasiecznik K.
    Diagn Microbiol Infect Dis; 1983 Dec 07; 1(4):287-93. PubMed ID: 6321092
    [Abstract] [Full Text] [Related]

  • 10. Treatment of pediatric infections with amikacin as first-line aminoglycoside.
    Shulman ST, Yogev R.
    Am J Med; 1985 Jul 15; 79(1A):43-50. PubMed ID: 4025367
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
    Peterson LR, Gerding DN, Moody JA, Fasching CE.
    Antimicrob Agents Chemother; 1984 May 15; 25(5):545-52. PubMed ID: 6329087
    [Abstract] [Full Text] [Related]

  • 14. Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
    Gerding DN, Peterson LR, Moody JA, Fasching CE.
    J Antimicrob Chemother; 1985 Jan 15; 15 Suppl A():207-19. PubMed ID: 3856563
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Amikacin therapy for serious gram-negative infection.
    Pollock AA, Berger SA, Richmond AS, Simberkoff MS, Rahal JJ.
    JAMA; 1977 Feb 07; 237(6):562-4. PubMed ID: 576282
    [Abstract] [Full Text] [Related]

  • 17. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR, Greenman RL, Hoffman TA.
    Arch Intern Med; 1978 May 07; 138(5):713-6. PubMed ID: 348135
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides.
    Gombert ME, Aulicino TM.
    Antimicrob Agents Chemother; 1983 Nov 07; 24(5):810-1. PubMed ID: 6362558
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.